Altimmune (FRA:3G0) FCF Margin %: 0.00% (As of Mar. 2026)


FRA:3G0 Altimmune Inc FRA:3G0
28 GF Score
Price €2.51
! 2 Warning Signs
View Full Analysis

What is Altimmune FCF Margin %?

Altimmune FRA:3G0 -1.96% 28 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates FRA:3G0 with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 958 Biotechnology companies, Altimmune ranks worse than 98.85% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Altimmune's Free Cash Flow for the three months ended in Mar. 2026 was €-18.13 Mil. Altimmune's Revenue for the three months ended in Mar. 2026 was €0.00 Mil. Therefore, Altimmune's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Altimmune's current FCF Yield % is -13.07%.

The historical rank and industry rank for Altimmune's FCF Margin % or its related term are showing as below:

FRA:3G0' s FCF Margin % Range Over the Past 10 Years
Min: -399240   Med: -1013.36   Max: 92223.53
Current: -205513.33

During the past 13 years, the highest FCF Margin % of Altimmune was 92223.53%. The lowest was -399240.00%. And the median was -1013.36%.

FRA:3G0's FCF Margin % is ranked worse than
98.85% of 958 companies
in the Biotechnology industry
Industry Median: -85.21 vs FRA:3G0: -205513.33

Altimmune FCF Margin % Related Terms

Altimmune FCF Margin % Historical Data

* Premium members only.

The historical data trend for Altimmune's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Altimmune FCF Margin % Chart

Altimmune Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,053.22 92,500.00 -17,790.54 -401,342.11 -164,811.43

Altimmune Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -311,540.00 -419,400.00 -253,400.00 -75,495.45 0.00

FRA:3G0 vs TECX, EIKN, ARVN: FCF Margin % Comparison

For the Biotechnology subindustry, Altimmune's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Altimmune FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Altimmune's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Altimmune's FCF Margin % falls into.


FRA:3G0
28GF Score
Altimmune Inc FRA:3G0
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Altimmune FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Altimmune's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-57.684/0.035
=-164,811.43 %

Altimmune's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-18.133/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Altimmune (FRA:3G0) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Altimmune and its competitors. According to the industry distribution chart, Altimmune ranks #947 out of 958 companies in the Biotechnology industry, placing it in the top 98.9%.
Is Altimmune's FCF Margin % too high?
Altimmune's current FCF Margin % is 0.00%. Based on the distribution chart, Altimmune ranks #947 out of 958 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Altimmune has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Altimmune's FCF Margin % compare to TECX and EIKN?
According to the Biotechnology industry distribution chart, Altimmune ranks #947 out of 958 companies for FCF Margin %. This places Altimmune in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Altimmune and its competitors. Altimmune's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Altimmune stock overvalued right now?
Altimmune (FRA:3G0) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Altimmune's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Altimmune (FRA:3G0), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Altimmune Business Description

Address 910 Clopper Road, Suite 201S, Gaithersburg, MD, USA, 20878
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
28GF Score

Get the complete analysis for FRA:3G0

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.51
Price